<!DOCTYPE html>
<html lang="en-us">
  <head>
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1">
    
    <title>Posts | Fallingstar Daily R</title>
    <link rel="stylesheet" href="/css/style.css" />
    <link rel="stylesheet" href="/css/fonts.css" />
    <link href="//cdn.bootcss.com/highlight.js/9.12.0/styles/github.min.css" rel="stylesheet">

  </head>

  <body>
    <nav class="header">
      <div class="banner">
<a href="/" class="text">
&Ffr;&Afr;&Lfr;&Lfr;&Ifr;&Nfr;&Gfr;&Sfr;&Tfr;&Afr;&Rfr; &Dfr;&Afr;&Ifr;&Lfr;&Yfr; &Rfr;
</a>
</div>

      <div class="head-meta">
      
        <span>Posts</span>
        <span>2024-10-17</span>
      
      </div>
    </nav>


<div class="container">
<main class="list">

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39415381/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241017182615&amp;v=2.18.0.post9&#43;e462414">Prognostic Impact of Admission Time in Infarct-Related Cardiogenic Shock: An ECLS-SHOCK Substudy</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-17</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39415381-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241017182615-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: The prognosis in AMI-CS was not affected by admission time with a similar effect of ECLS during on- and &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39415509/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241017182615&amp;v=2.18.0.post9&#43;e462414">Therapy adherence after interdisciplinary tumour board discussion is associated with improved outcome in soft tissue sarcoma: A CharitÃ© Comprehensive Cancer Centre analysis</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-17</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39415509-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241017182615-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Centralising soft tissue sarcoma (STS) treatment in expert centres and implementing comprehensive therapy concepts through interdisciplinary tumour boards (ITB) has led to significant treatment progress. However, our knowledge on the implementation of the ITB recommendations and its impact on patient outcome is limited. In this retrospective analysis, we examined a cohort of 222 adult patients (pts) with primary STS who were presented to the ITB of the CharitÃ© Comprehensive Cancer Centre &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39415807/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241017182615&amp;v=2.18.0.post9&#43;e462414">Recommendations for reviewing manuscripts of the article types &#34;project report&#34; and &#34;how to&#34; for the GMS Journal for Medical Education</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-17</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39415807-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241017182615-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: A manuscript lacking core elements will be rejected. If aspects are not described sufficiently or are not clearly comprehensible, the manuscript must be &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39415879/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241017182615&amp;v=2.18.0.post9&#43;e462414">Evidence gaps in conservative non-pharmacological interventions and guideline implementation for high-burden non-communicable diseases: protocol for an overview of reviews</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-17</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39415879-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241017182615-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Non-communicable diseases (NCDs) represent a high burden for the society and affected individuals. Conservative non-pharmacological interventions play a first-line role in the treatment and management of most NCDs. Systematic reviews (SRs) provide the highest level of evidence and significantly influence clinical decision-making. The primary aim of this study is to provide an overview of the evidence on the effectiveness of recommended conservative non-pharmacological interventions for &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39415890/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241017182615&amp;v=2.18.0.post9&#43;e462414">Close, yet so far away: a phenomenology of the praecox feeling in the diagnosis of schizophrenia as intercorporeal alienness</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-17</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39415890-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241017182615-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Debates concerning the reliability and validity of operationalized criteria and diagnostic tools have surrounded the issue of schizophrenia diagnosis and clinical decision-making related to the disorder. The notion of the praecox feeling (PF) has played a prominent role in the discussions as an example of the possibility of a rapid and potentially valid diagnosis based solely on &ldquo;intuition&rdquo; or a peculiar emotional experience or impression arising in a physician during an interaction with &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39415900/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241017182615&amp;v=2.18.0.post9&#43;e462414">A phase 1b/2 study evaluating efficacy and safety of MP0250, a designed ankyrin repeat protein (DARPin) simultaneously targeting vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF), in combination with bortezomib and dexamethasone, in patients with relapsed or refractory multiple myeloma</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-17</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39415900-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241017182615-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    MP0250 is a designed ankyrin repeat protein that specifically inhibits both vascular endothelial growth factor A (VEGF-A) and hepatocyte growth factor (HGF), aiming at potentiating cancer therapy by disrupting the tumour microenvironment. Encouraging results from a phase 1 trial of MP0250 in patients with solid tumours prompted further investigation in multiple myeloma (MM) as both MP0250 targets are reported to be drivers of MM pathogenesis. In this open-label, single-arm phase 1b/2 &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39416942/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241017182615&amp;v=2.18.0.post9&#43;e462414">Barriers and facilitators to dissemination of non-communicable diseases research: a mixed studies systematic review</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-17</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39416942-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241017182615-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Researchers and government organisations should consider these factors when identifying ways to disseminate research findings to decision-maker audiences. Future research should aim to build the evidence base on different strategies to overcome these &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39417025/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241017182615&amp;v=2.18.0.post9&#43;e462414">Patient characteristics of completion and dropout of mentalization-based treatment for adolescents with conduct disorder</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-17</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39417025-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241017182615-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    INTRODUCTION: Conduct disorder (CD) is a severe mental disorder in youth. Yet, providing psychological interventions for adolescents with CD is challenging. This patient group is often characterized by risk factors for therapy dropout such as, e.g., CD symptoms and being in middle adolescence. On the other hand, little is known about characteristics of adolescents with CD who complete treatment. To gain more insight into what might become a successful therapy with adolescents with CD, this &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39417321/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1x5bM_TNL8gjogAcnslpo2s2PbDe-61JVM2h9yowOYSiZ7Dkrt&amp;fc=20220919211934&amp;ff=20241017182614&amp;v=2.18.0.post9&#43;e462414">scMGATGRN: a multiview graph attention network-based method for inferring gene regulatory networks from single-cell transcriptomic data</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-17</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39417321-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1x5bm-tnl8gjogacnslpo2s2pbde-61jvm2h9yowoysiz7dkrt-fc-20220919211934-ff-20241017182614-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The gene regulatory network (GRN) plays a vital role in understanding the structure and dynamics of cellular systems, revealing complex regulatory relationships, and exploring disease mechanisms. Recently, deep learning (DL)-based methods have been proposed to infer GRNs from single-cell transcriptomic data and achieved impressive performance. However, these methods do not fully utilize graph topological information and high-order neighbor information from multiple receptive fields. To &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39417383/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241017182615&amp;v=2.18.0.post9&#43;e462414">Diels-Alder Reactivity of Triisopropylsilyl Ethynyl Substituted Acenes</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-17</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39417383-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241017182615-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    We investigated the Diels-Alder reaction of 6,13-bis(triisopropylsilyl)pentacene (1) with small dienophiles such as (bridged) dihydronaphthalenes/cyclohexenes that yielded adducts at the central ring, the other dienophiles predominantly or exclusively attacked the unsubstituted off-center ring. The difference in regioselectivity was investigated by DFT calculations. Apart from dispersion interactions, it is due to the steric demand of the dienophiles, which need to fit in between &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39417395/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241017182615&amp;v=2.18.0.post9&#43;e462414">Nine-fold variation of risk of advanced colorectal neoplasms according to smoking and polygenic risk score: Results from a cross-sectional study in a large screening colonoscopy cohort</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-17</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39417395-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241017182615-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39417661/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241017182615&amp;v=2.18.0.post9&#43;e462414">Implications of TRPM3 and TRPM8 for sensory neuron sensitisation</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-17</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39417661-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241017182615-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Sensory neurons serve to receive and transmit a wide range of information about the conditions of the world around us as well as the external and internal state of our body. Sensitisation of these nerve cells, i.e. becoming more sensitive to stimuli or the emergence or intensification of spontaneous activity, for example in the context of inflammation or nerve injury, can lead to chronic diseases such as neuropathic pain. For many of these disorders there are only very limited treatment &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39417851/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241017182615&amp;v=2.18.0.post9&#43;e462414">Surgical treatment of trigeminal pain</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-17</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39417851-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241017182615-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Surgical procedures for treating neuropathic pain, including trigeminal neuralgia (TGN), are categorized into three groups: decompression, ablation, and neuromodulation. Microvascular decompression is the only causal therapy for TGN, applicable favorably in cases of classical TGN due to a vascular nerve conflict. Ablative procedures include both percutaneous and radiosurgical methods, which are mainly used for idiopathic trigeminal neuralgia. For irreversible neuropathies of the &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39417857/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241017182615&amp;v=2.18.0.post9&#43;e462414">Planetary health and mental health</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-17</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39417857-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241017182615-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Climate change is the greatest global health threat of the twenty-first century. Greenhouse gas emissions and the resulting rise in average temperatures are directly linked to heatwaves, droughts, water and food shortages, extreme weather events, rising sea levels and migration movements as well as the loss of biodiversity and the alteration and degradation of ecosystems as we know them. Current estimates suggest that societies need to show much greater efforts to ensure that the global &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39417891/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241017182615&amp;v=2.18.0.post9&#43;e462414">DNAJC13 influences responses of the extended reward system to conditioned stimuli: a genome-wide association study</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-17</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39417891-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241017182615-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Reward system dysfunction is implicated in the pathogenesis of major psychiatric disorders. We conducted a genome-wide association study (GWAS) to identify genes that influence activation strength of brain regions within the extended reward system in humans. A homogeneous sample of 214 participants was genotyped and underwent functional magnetic resonance imaging (fMRI). All subjects performed the &lsquo;desire-reason dilemma&rsquo; (DRD) paradigm allowing systematic investigation of &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39418030/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20241017182559&amp;v=2.18.0.post9&#43;e462414">Long-noncoding vulnerabilities in MM</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-17</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39418030-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20241017182559-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39418031/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20241017182559&amp;v=2.18.0.post9&#43;e462414">Favism with methemoglobinemia</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-17</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39418031-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20241017182559-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39418032/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20241017182559&amp;v=2.18.0.post9&#43;e462414">&#34;Lymphorepletion&#34; by IL-15</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-17</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39418032-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20241017182559-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39418033/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20241017182559&amp;v=2.18.0.post9&#43;e462414">Platelets are hot and cold, RhoA is up and down</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-17</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39418033-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20241017182559-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39418034/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20241017182559&amp;v=2.18.0.post9&#43;e462414">Platelets burst your bubble</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-17</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39418034-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20241017182559-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39418035/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20241017182559&amp;v=2.18.0.post9&#43;e462414">New HLA-DPB1 T-cell epitope model for mismatched UR-HCT</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-17</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39418035-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20241017182559-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39418036/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20241017182559&amp;v=2.18.0.post9&#43;e462414">Impact of TP53 in MDS with isolated del(5q)</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-17</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39418036-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20241017182559-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39418037/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20241017182559&amp;v=2.18.0.post9&#43;e462414">Taming the flame: WAS and IL-1 blockade</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-17</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39418037-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20241017182559-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39418038/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20241017182559&amp;v=2.18.0.post9&#43;e462414">Impact of TP53 abnormalities in MDS-del(5q)</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-17</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39418038-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20241017182559-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/OBVunxpED">ä¸€ç¯‡è®ºæ–‡ï¼Œå¦‚æœæ˜¯æˆ‘å†™çš„ï¼Œè®©åˆ«äººå®¡ï¼Œåˆ«äººä¼šè§‰å¾—é€šç¯‡æ˜¯æ¯›ç—…ï¼›åŒç†ï¼Œå¦‚æœæ˜¯åˆ«äººå†™çš„ï¼Œè®©æˆ‘æ¥å®¡ï¼Œæˆ‘ä¼šå¼ºè¿«ç—‡çˆ†å‘ï¼Œä»æ•°æ®æœ‰å‡ºå…¥ï¼Œåˆ°è§’æ ‡ä¸æ­£ç¡®ï¼Œåˆ°ç¼©å†™å’Œç¼©è¿›å‰åä¸...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-17</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-obvunxped/">
    
    
    
    
    
      
    
    ä¸€ç¯‡è®ºæ–‡ï¼Œå¦‚æœæ˜¯æˆ‘å†™çš„ï¼Œè®©åˆ«äººå®¡ï¼Œåˆ«äººä¼šè§‰å¾—é€šç¯‡æ˜¯æ¯›ç—…ï¼›åŒç†ï¼Œå¦‚æœæ˜¯åˆ«äººå†™çš„ï¼Œè®©æˆ‘æ¥å®¡ï¼Œæˆ‘ä¼šå¼ºè¿«ç—‡çˆ†å‘ï¼Œä»æ•°æ®æœ‰å‡ºå…¥ï¼Œåˆ°è§’æ ‡ä¸æ­£ç¡®ï¼Œåˆ°ç¼©å†™å’Œç¼©è¿›å‰åä¸ä¸€è‡´ï¼ŒåŸºæœ¬èƒ½å¸®åˆ«äººé‡å†™ä¸€éã€‚æ‰€ä»¥å®¡ç†åˆ«äººçš„æ–‡ç« ï¼Œéƒ½ä¼šæœ‰ç§ä¸Šå¸è§†è§’ï¼Œè§‰å¾—åˆ«äººincompetentï¼Œè§‰å¾—åˆ«äººæ€ä¹ˆé‚£ä¹ˆè ¢ã€‚å¾ˆå¤šè€æ¿çœ‹å­¦ç”Ÿä¹Ÿè¿™æ ·ï¼Œä½†reviewerçœ‹ä»–ä»¬çš„æ–‡ç« ä¹Ÿä¼šæœ‰åŒæ„Ÿã€‚ &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/OBWrriSxp">å¸®ä¸€ä¸ªæœ‹å‹å»Habitä¹°åƒåœ¾é£Ÿå“ï¼Œç„¶åçœ‹åˆ°ä»–ä»¬æ–°å‡ºçš„å·§å…‹åŠ›åœ£ä»£ï¼Œæ‹·é—®äº†çµé­‚ä¸€åˆ†é’Ÿï¼Œæœ€åè¿˜æ˜¯ä¹°äº†ã€‚æˆ‘ä¸Šæ˜ŸæœŸå‘Šè¯‰ä¸€ä¸ªæœ‹å‹ï¼Œä½œä¸ºå­¦åŒ»çš„æœ€æƒ¨çš„ä¸€ç‚¹æ˜¯ä½ è¦å—åˆ°åŒé‡æŠ˜...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-17</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-obwrrisxp/">
    
    
    
    
    
      
    
    å¸®ä¸€ä¸ªæœ‹å‹å»Habitä¹°åƒåœ¾é£Ÿå“ï¼Œç„¶åçœ‹åˆ°ä»–ä»¬æ–°å‡ºçš„å·§å…‹åŠ›åœ£ä»£ï¼Œæ‹·é—®äº†çµé­‚ä¸€åˆ†é’Ÿï¼Œæœ€åè¿˜æ˜¯ä¹°äº†ã€‚æˆ‘ä¸Šæ˜ŸæœŸå‘Šè¯‰ä¸€ä¸ªæœ‹å‹ï¼Œä½œä¸ºå­¦åŒ»çš„æœ€æƒ¨çš„ä¸€ç‚¹æ˜¯ä½ è¦å—åˆ°åŒé‡æŠ˜ç£¨ï¼ˆå¯¹äºå…¶ä»–äººåªæœ‰ä¸€é‡ï¼‰ï¼š1. åƒè¿™äº›å¯¹èº«ä½“ä¸å¥½ â€” æ¯”å¦‚åƒé«˜ç³–é£Ÿç‰©ã€é¥±å’Œè„‚è‚ªé…¸é£Ÿç‰©å’Œultra processedé£Ÿç‰©ï¼Œé™¤äº†æŸå®³æ¶ˆåŒ–é“ã€æ¶ˆåŒ–è…ºã€å†…åˆ†æ³Œå’Œä»£è°¢ç³»ç»Ÿï¼Œè¿˜æŸå®³å¿ƒè„‘è¡€ç®¡ç³»ç»Ÿï¼›2. ä½ çŸ¥é“è¿™ä¹ˆåšå¯¹èº«ä½“æœ‰å¤šä¸å¥½ â€” ä½ æ„è¯†åˆ°äº†è¿™äº›æŸå®³ï¼Œè¿˜åœ¨è„‘ä¸­ä¸æ–­æ¼”ç»ç—…ç†å˜åŒ–ï¼Œæ¯”å¦‚oxLDLå¦‚ä½•æ¯’åŒ–è¡€ç®¡å†…çš®ç»†èƒï¼Œç„¶åå¢åŠ äº†å¾ˆå¤šå¿ƒç†å‹åŠ›ã€ç„¦è™‘å’Œè‡ªè´£ã€‚è¿™å«åšâ€œå­¦åŒ»åŒé‡æ‰“å‡»å­¦è¯´â€ã€‚ &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1251560221/OBYlvDXlO">é‡ç£…ä¸´åºŠç ”ç©¶ â€” HIVæ„ŸæŸ“è€…å¯ä»¥æä¾›å®‰å…¨è‚¾æºï¼Œç»™äºˆå…¶ä»–HIVæ„ŸæŸ“è€…ä½œä¸ºè‚¾ç§»æ¤ä¾›ä½“ï¼Œè€ŒHIVè‚¾ç§»æ¤æ‰‹æœ¯å¯¹äºåŒ»åŠ¡äººå‘˜ååˆ†å®‰å…¨ã€‚ä»Šå¤©Johns Hopkinsé¢†è¡”çš„HOPEç ”ç©¶ï¼ˆNCT0...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-17</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1251560221-obylvdxlo/">
    
    
    
    
    
      
    
    é‡ç£…ä¸´åºŠç ”ç©¶ â€” HIVæ„ŸæŸ“è€…å¯ä»¥æä¾›å®‰å…¨è‚¾æºï¼Œç»™äºˆå…¶ä»–HIVæ„ŸæŸ“è€…ä½œä¸ºè‚¾ç§»æ¤ä¾›ä½“ï¼Œè€ŒHIVè‚¾ç§»æ¤æ‰‹æœ¯å¯¹äºåŒ»åŠ¡äººå‘˜ååˆ†å®‰å…¨ã€‚ä»Šå¤©Johns Hopkinsé¢†è¡”çš„HOPEç ”ç©¶ï¼ˆNCT03500315ï¼‰åœ¨å‘¨ä¸‰ä¸Šçº¿çš„NEJMä½œä¸ºå¤´ç‰ˆç ”ç©¶è®ºæ–‡å‘è¡¨ã€‚è¿™é¡¹ç ”ç©¶æ˜¯æä¸ºé‡è¦çš„HIVå®ç”¨åŒ»ç–—ç ”ç©¶ã€‚2016å¹´ï¼Œç¾å›½å›½ä¼šé€šè¿‡HIV Organ Policy Equity Act â€” HIVæ„ŸæŸ“è€…å™¨å®˜ç§»æ¤å…¬å¹³æ”¿ç­–æ³•æ¡ˆï¼Œé¦–æ¬¡åˆæ³•åŒ–äº†å°†HIVæ„ŸæŸ“è€…çš„å™¨å®˜ç§»æ¤ç»™å…¶ä»–HIVæ„ŸæŸ“è€…ã€‚ç¾å›½å«ç”Ÿéƒ¨ï¼ˆDHHSï¼‰æ­£åœ¨ä¿®æ”¹ä¸´åºŠå®è·µæŒ‡å—ï¼Œä»¥è®©è¿™ä¸ªæ³•æ¡ˆå¾—åˆ°è¿›ä¸€æ­¥è½å®ï¼›è€Œè¿™é¡¹ç ”ç©¶æ­£æ»¡è¶³äº†è¿™ä¸€éœ€æ±‚å¹¶å¡«è¡¥äº†ç©ºç™½ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted -->è¿™é¡¹ç ”ç©¶åœ¨ç¾å›½26ä¸ªä¸´åºŠä¸­å¿ƒå¼€å±•äº†ä¸€é¡¹å¤šä¸­å¿ƒè§‚å¯Ÿæ€§ç ”ç©¶ï¼Œè¿™é¡¹ç ”ç©¶éš¾å¾—å¯è´µçš„æ˜¯è®¾ç½®äº†å¯¹ç…§ï¼Œå³ç”¨éæ„ŸæŸ“è€…è‚¾ç§»æ¤ç»™HIVæ„ŸæŸ“è€…ï¼Œä¸ç”¨HIVæ„ŸæŸ“è€…è‚¾ç§»æ¤ç»™HIVæ„ŸæŸ“è€…ç›¸æ¯”è¾ƒï¼Œæ¥å¯¹æ¯”ä¸¤è€…çš„å¼‚åŒ &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OBZAHfj8A">ä¸æ˜¯ï¼Œå¤©ç”Ÿå°åº¦äººï¼ŒæŠŠåŒ—ç¾æ´»æ˜ç™½é‚£ç§ã€‚//@æ»‘ç¨½æ ‘ç»“æ»‘ç¨½æœ:çœŸçš„æ˜¯å¤©ç”Ÿç¾å›½äººï¼Œå¤ªç‰›é€¼äº† - è½¬å‘ @åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´:&amp;ensp;ğŸ”»ç½‘å‹åˆ†äº«ï¼šåäº†ï¼Œç»™è®²å¸ˆæ•´æˆç•™å­¦ç”Ÿäº†ã€‚...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-17</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-obzahfj8a/">
    
    
    
    
    
      
    
    ä¸æ˜¯ï¼Œå¤©ç”Ÿå°åº¦äººï¼ŒæŠŠåŒ—ç¾æ´»æ˜ç™½é‚£ç§ã€‚//<!-- raw HTML omitted -->@æ»‘ç¨½æ ‘ç»“æ»‘ç¨½æœ<!-- raw HTML omitted -->:çœŸçš„æ˜¯å¤©ç”Ÿç¾å›½äººï¼Œå¤ªç‰›é€¼äº†<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´<!-- raw HTML omitted -->:â€‚ğŸ”»ç½‘å‹åˆ†äº«ï¼šåäº†ï¼Œç»™è®²å¸ˆæ•´æˆç•™å­¦ç”Ÿäº†ã€‚<!-- raw HTML omitted -->ğŸ”»ç¾å›½è€ç™½äººMAGAçœŸçš„è¦æ°”æ­»äº†ã€‚ <!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax2.sinaimg.cn/large/639b1bfbly">https://tvax2.sinaimg.cn/large/639b1bfbly</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OBZDtvvYy">ğŸ”»éšç€æ­¤æ¶ˆå½¼é•¿ï¼ŒæŒ‰ç…§ğŸ¸è¿™ä¸ªè‰æœ¨çš†å…µæƒŠæä¸‡åˆ†çš„ç¨‹åº¦ï¼ŒğŸ¸ä¸€æ³¢åˆä¸€æ³¢çš„å¥½æ—¥å­è¿˜åœ¨åé¢å‘¢ã€‚ğŸ”»æˆ‘çœ‹è¿™è¢«è¿«æˆä¸ºåŒè·¯äººçš„å°æ¹¾çœå±…æ°‘ï¼Œæ€•æ˜¯ä¸å¾—ä¸è¶Šæ¥è¶Šå¤šã€‚ [å›¾...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-17</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-obzdtvvyy/">
    
    
    
    
    
      
    
    ğŸ”»éšç€æ­¤æ¶ˆå½¼é•¿ï¼ŒæŒ‰ç…§ğŸ¸è¿™ä¸ªè‰æœ¨çš†å…µæƒŠæä¸‡åˆ†çš„ç¨‹åº¦ï¼ŒğŸ¸ä¸€æ³¢åˆä¸€æ³¢çš„å¥½æ—¥å­è¿˜åœ¨åé¢å‘¢ã€‚<!-- raw HTML omitted -->ğŸ”»æˆ‘çœ‹è¿™è¢«è¿«æˆä¸ºåŒè·¯äººçš„å°æ¹¾çœå±…æ°‘ï¼Œæ€•æ˜¯ä¸å¾—ä¸è¶Šæ¥è¶Šå¤šã€‚ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;source src=&ldquo;<a href="https://f.video.weibocdn.com/o0/auAXwQpqlx08iRIGlMuQ01041200cLMj0E01">https://f.video.weibocdn.com/o0/auAXwQpqlx08iRIGlMuQ01041200cLMj0E01</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OBZnx8CHd">ğŸ”»æ­¦è­¦ç¬¬äºŒæœºåŠ¨æ€»é˜ŸæŸæ”¯é˜Ÿäºæ´‹ã€å´å¤ã€é™¶ç”¨ã€å…°å¿—è±ªç­‰åˆ›ä½œçš„MVğŸ”»via äººæ°‘æ­¦è­¦ğŸ”»ç»ˆäºçœ‹åˆ°èˆ±é—¨æœºæªæ¶äº†[å“†å•¦Aæ¢¦åƒæƒŠ] [å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-17</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-obznx8chd/">
    
    
    
    
    
      
    
    ğŸ”»æ­¦è­¦ç¬¬äºŒæœºåŠ¨æ€»é˜ŸæŸæ”¯é˜Ÿäºæ´‹ã€å´å¤ã€é™¶ç”¨ã€å…°å¿—è±ªç­‰åˆ›ä½œçš„MV<!-- raw HTML omitted -->ğŸ”»via äººæ°‘æ­¦è­¦<!-- raw HTML omitted -->ğŸ”»ç»ˆäºçœ‹åˆ°èˆ±é—¨æœºæªæ¶äº†<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax3.sinaimg.cn/large/639b1bfbgy1hupllgojtij20zu0l9q7f.jpg%22">https://tvax3.sinaimg.cn/large/639b1bfbgy1hupllgojtij20zu0l9q7f.jpg&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OBZqb0PeT">ğŸ”»ã€Šå…­æœã€‹çš„åè®°é‡Œï¼Œä½œè€…è‡ªå·±å†™çš„å¾ˆæ¸…æ¥šäº†ï¼šğŸ”¹æœ¬é›†åè®°æœ‰è¯»è€…é—®èµ·å…­æœè¿™éƒ¨ä½œå“çš„ä¸»è½´ï¼Œè‹¦æ€è‰¯ä¹…åï¼Œå†³å®šè¿™æ ·å›ç­”ã€‚å…­æœçš„ç›®çš„ï¼Œåœ¨äºâ€”â€”å…¨é¢æ¢³ç†è‡ªä¸Šå¤è‡³å®‹...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-17</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-obzqb0pet/">
    
    
    
    
    
      
    
    ğŸ”»ã€Šå…­æœã€‹çš„åè®°é‡Œï¼Œä½œè€…è‡ªå·±å†™çš„å¾ˆæ¸…æ¥šäº†ï¼š<!-- raw HTML omitted -->ğŸ”¹æœ¬é›†åè®°æœ‰è¯»è€…é—®èµ·å…­æœè¿™éƒ¨ä½œå“çš„ä¸»è½´ï¼Œè‹¦æ€è‰¯ä¹…åï¼Œå†³å®šè¿™æ ·å›ç­”ã€‚å…­æœçš„ç›®çš„ï¼Œåœ¨äºâ€”â€”å…¨é¢æ¢³ç†è‡ªä¸Šå¤è‡³å®‹ä»£çš„å¤ä»£æ€æƒ³å²ï¼Œæ•´ç†å†ä»£å†›äº‹ã€ç§‘æŠ€ã€ç»æµã€æ³•å¾‹ã€æ”¿æ²»ç»“æ„ã€å®—æ•™å½±å“ã€äººæ–‡è‰ºæœ¯å‘å±•ï¼Œä»¥åŠäººç‰©æ€æƒ³åŠ¨æ€ï¼Œä»å¾®è§‚åˆ°å®è§‚ï¼Œä»ä¸ªä½“åˆ°ç¾¤ä½“ï¼Œåˆ†æåˆ©å¼Šå¾—å¤±ã€‚<!-- raw HTML omitted -->ğŸ”¹å¦‚æœä»¥ä¸ºè¿™æ˜¯å…¨éƒ¨ï¼Œé‚£å°±é”™äº†ã€‚<!-- raw HTML omitted -->ğŸ”¹è¿™åªæ˜¯ç¬¬ä¸€æ­¥â€”â€”æ›´é‡è¦çš„åœ¨äºä¸åŒæœä»£ä¸åŒæ€æƒ³ä¸åŒäººç‰©ä¹‹é—´çš„äº¤æµä¸ç¢°æ’ï¼Œæ¼”ç»ä¸€åœºé£æµäººç‰©ã€ç»å…¸æ•…äº‹ã€æ™ºæ…§ä¸å‹‡æ°”å¦‚æœä»¥ä¸ºè¿™æ˜¯å…¨éƒ¨ï¼Œé‚£ä¹Ÿé”™äº†ã€‚<!-- raw HTML omitted -->ğŸ”¹æ›´æ›´é‡è¦çš„ä¹Ÿåœ¨äºå¤äººé¢å¯¹ç°ä»£ç§‘æŠ€ã€çŸ¥è¯†æ—¶çš„ååº”ä¸å¯¹ç­–ã€‚çœ‹å†å²è¿™ä¸ªæ³¥è¶³çš„å·¨äººå¦‚ä½•æ‰­æ›²è€Œåˆé¡½å›ºåœ°è‡ªæˆ‘å‘å±•ï¼Œåœ¨ç©¿è¶Šè€…çš„é‡å‡»ä¸‹ï¼Œå¦‚ä½•è¹’è·šå‰è¡Œã€‚<!-- raw HTML omitted -->ğŸ”¹å¦‚æœä»¥ä¸ºè¿™æ˜¯å…¨éƒ¨ï¼Œé‚£è¿˜æ˜¯é”™äº†ã€‚&lt;b &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OBZqBFILJ">ç®€å•çš„è¯´ï¼Œå¦‚æœä¼Šæœ—å’Œä¸Šæ¬¡ä¸€æ ·æ‰“200å‘ï¼Œé‚£å°±ç®—åŠ äº†ä¸€å¥—è¨å¾·è‚¯å®šä¹Ÿæ˜¯æ¥ä¸ä½çš„ã€‚//@ä¼˜æ‚ è›‹ç³•åº—:å°ç™½é—®ä¸‹ï¼Œä»¥è‰²åˆ—è‡ªå·±çš„ç®­å’Œå…¶ä»–çš„é˜²æ§ä¼šæ¯”è¨å¾·å·®å—ï¼Œè¿˜æœ‰å®ƒèƒ½æ¥å¤š...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-17</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-obzqbfilj/">
    
    
    
    
    
      
    
    ç®€å•çš„è¯´ï¼Œå¦‚æœä¼Šæœ—å’Œä¸Šæ¬¡ä¸€æ ·æ‰“200å‘ï¼Œé‚£å°±ç®—åŠ äº†ä¸€å¥—è¨å¾·è‚¯å®šä¹Ÿæ˜¯æ¥ä¸ä½çš„ã€‚//<!-- raw HTML omitted -->@ä¼˜æ‚ è›‹ç³•åº—<!-- raw HTML omitted -->:å°ç™½é—®ä¸‹ï¼Œä»¥è‰²åˆ—è‡ªå·±çš„ç®­å’Œå…¶ä»–çš„é˜²æ§ä¼šæ¯”è¨å¾·å·®å—ï¼Œè¿˜æœ‰å®ƒèƒ½æ¥å¤šå°‘å¼¹é“å¯¼å¼¹ï¼Œå—å¾—äº†å—<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´<!-- raw HTML omitted -->:â€‚ğŸ”»ç°åœ¨ï¼šå†…å¡”å°¼äºšèƒ¡å‚è§‚ç¾å†›åœ¨ä»¥è‰²åˆ—çš„éƒ¨ç½²åœ°ç‚¹å’Œè¨å¾·ç³»ç»Ÿã€‚<!-- raw HTML omitted -->ğŸ”»ä¼°è®¡å¯¹ä¼Šæœ—çš„æŠ¥å¤å¿«äº†ã€‚<!-- raw HTML omitted -->ğŸ”»è¿™ä¸‹å¯èƒ½è¦å®é™…æ£€éªŒä¸€ä¸‹è¨å¾·çš„æ•ˆæœã€‚<!-- raw HTML omitted -->ğŸ”»via N12.il <!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; src=&ldquo;<a href="https://h5.sinaimg.cn/upload/2015/09/25/3/timeline_card_">https://h5.sinaimg.cn/upload/2015/09/25/3/timeline_card_</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OBZrvf4a2">æ®‹ç–¾æ¯”å—ä¼¤ä¸¥é‡å¤šäº†//@å¤©é“ç·å¸çš„å°é™¢:åŒ…å§ï¼Œä¸æ˜¯1ï¼š3å—ï¼Ÿ//@åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´:æ®‹ç–¾å’Œé˜µäº¡ç²—ç•¥å¯ä»¥æŒ‰ 1ï¼š1 ç®—ã€‚//@è¿˜è¡Œä¸‹ä¸€ä¸ª:ä¸€èˆ¬æ®‹ç–¾å’Œé˜µäº¡æ¯”ä¾‹æ˜¯å¤šå°‘ï¼Œæœ‰äººç»Ÿè®¡...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-17</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-obzrvf4a2/">
    
    
    
    
    
      
    
    æ®‹ç–¾æ¯”å—ä¼¤ä¸¥é‡å¤šäº†//<!-- raw HTML omitted -->@å¤©é“ç·å¸çš„å°é™¢<!-- raw HTML omitted -->:åŒ…å§ï¼Œä¸æ˜¯1ï¼š3å—ï¼Ÿ//<!-- raw HTML omitted -->@åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´<!-- raw HTML omitted -->:æ®‹ç–¾å’Œé˜µäº¡ç²—ç•¥å¯ä»¥æŒ‰ 1ï¼š1 ç®—ã€‚//<!-- raw HTML omitted -->@è¿˜è¡Œä¸‹ä¸€ä¸ª<!-- raw HTML omitted -->:ä¸€èˆ¬æ®‹ç–¾å’Œé˜µäº¡æ¯”ä¾‹æ˜¯å¤šå°‘ï¼Œæœ‰äººç»Ÿè®¡è¿‡å—<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´<!-- raw HTML omitted -->:â€‚ğŸ”»æ³½è¿æ–¯åŸºçš„è€å©†è¯´æ¼å˜´äº†ï¼Œä¹Œå…‹å…°ä¸¤å¹´æ–°å¢30ä¸‡æ®‹ç–¾äººã€‚<!-- raw HTML omitted -->ğŸ”»å äººå£çš„çº¦1-1.5%ï¼Œå¯ä»¥è¯´éå¸¸mildäº† &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OBZvZ4dtJ">ğŸ”»ç½‘å‹åˆ†äº«ï¼šåäº†ï¼Œç»™è®²å¸ˆæ•´æˆç•™å­¦ç”Ÿäº†ã€‚ğŸ”»ç¾å›½è€ç™½äººMAGAçœŸçš„è¦æ°”æ­»äº†ã€‚ [å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-17</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-obzvz4dtj/">
    
    
    
    
    
      
    
    ğŸ”»ç½‘å‹åˆ†äº«ï¼šåäº†ï¼Œç»™è®²å¸ˆæ•´æˆç•™å­¦ç”Ÿäº†ã€‚<!-- raw HTML omitted -->ğŸ”»ç¾å›½è€ç™½äººMAGAçœŸçš„è¦æ°”æ­»äº†ã€‚ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax4.sinaimg.cn/large/639b1bfbly1huplzi2lbij2">https://tvax4.sinaimg.cn/large/639b1bfbly1huplzi2lbij2</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OBZxFEcj4">å› ä¸ºæ²³å›¾çš„å®ä½“ä¹¦å‡ºç‰ˆå®Œè›‹äº†ï¼Œåˆ«ä»¥ä¸ºå°æ¹¾å¾ˆå¥½èµšé’±å•Šâ€¦â€¦//@ç¥ç§˜ç«¹æµ·:ç½—æ£®è‡ªå·±å°æ¹¾äººï¼Œä»–è‡ªå·±åœ¨å°æ¹¾å†™æ ¹æœ¬æ²¡å•¥äº‹ï¼Œå®Œå…¨æƒ³ä¸é€šä»–å¤„äºå•¥ç›®çš„è·‘åˆ°å¤§é™†æ¥æ¥ç€æï¼Œå•çº¯...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-17</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-obzxfecj4/">
    
    
    
    
    
      
    
    å› ä¸ºæ²³å›¾çš„å®ä½“ä¹¦å‡ºç‰ˆå®Œè›‹äº†ï¼Œåˆ«ä»¥ä¸ºå°æ¹¾å¾ˆå¥½èµšé’±å•Šâ€¦â€¦//<!-- raw HTML omitted -->@ç¥ç§˜ç«¹æµ·<!-- raw HTML omitted -->:ç½—æ£®è‡ªå·±å°æ¹¾äººï¼Œä»–è‡ªå·±åœ¨å°æ¹¾å†™æ ¹æœ¬æ²¡å•¥äº‹ï¼Œå®Œå…¨æƒ³ä¸é€šä»–å¤„äºå•¥ç›®çš„è·‘åˆ°å¤§é™†æ¥æ¥ç€æï¼Œå•çº¯å‘†åœ¨å°æ¹¾å¾€å¤§é™†æä¹Ÿæ²¡é—®é¢˜ï¼Œä½†ä¸ºå•¥è‚‰èº«ä¹Ÿæ¥æ˜¯çœŸçœ‹ä¸æ‡‚è¿™æ“ä½œ //<!-- raw HTML omitted -->@hhjji201106<!-- raw HTML omitted -->:è¿™äº›äººéƒ½è¯¥æ¶¦äº†ï¼Œè¿™ä¹ˆå¥½çš„æ–‡ç¬”ï¼Œå¯¹å†å²æœ‰è‡ªå·±çš„è§è§£ï¼Œæ‰æŒ£30Wï¼ŒçœŸjbä¸å€¼ã€‚éšä¾¿å†™ç‚¹å›—æ°´ç½‘æ–‡ï¼Œä¸è½»è½»æ¾æŒ£ã€‚è‰¹ï¼ŒçœŸä¸å€¼è¢«è‡ªå·±çˆ±å¥½å‘äº†ã€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;span &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OC2DQCTjh">ğŸ”»ğŸ‡©ğŸ‡ªå¾·å›½æµ·å†›è·¯å¾·ç»´å¸Œæ¸¯è±èŒµå·æŠ¤å«èˆ°ï¼ˆF264ï¼‰åœ¨é»å·´å«©çº³å¤æ‹‰-æ‹‰å¸ƒå¥ˆåœ°åŒºé™„è¿‘å‡»è½ä¸€æ¶æ— äººæœºï¼Œä»¥è‰²åˆ—å†›é˜Ÿåœ¨è¿‡å»å‡ å°æ—¶å†…æŸå¤±äº† 4 è¾†å¦å…‹ã€‚ğŸ”»è®¸å¤šåˆ†æå®¶...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-17</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oc2dqctjh/">
    
    
    
    
    
      
    
    ğŸ”»ğŸ‡©ğŸ‡ªå¾·å›½æµ·å†›è·¯å¾·ç»´å¸Œæ¸¯è±èŒµå·æŠ¤å«èˆ°ï¼ˆF264ï¼‰åœ¨é»å·´å«©çº³å¤æ‹‰-æ‹‰å¸ƒå¥ˆåœ°åŒºé™„è¿‘å‡»è½ä¸€æ¶æ— äººæœºï¼Œä»¥è‰²åˆ—å†›é˜Ÿåœ¨è¿‡å»å‡ å°æ—¶å†…æŸå¤±äº† 4 è¾†å¦å…‹ã€‚<!-- raw HTML omitted -->ğŸ”»è®¸å¤šåˆ†æå®¶ä¸€ç›´æ€€ç–‘å¾·å›½åˆ©ç”¨è”é»éƒ¨é˜Ÿçš„èº«ä»½ä½œä¸ºå¸®åŠ©ä»¥è‰²åˆ—çš„å¹Œå­ï¼Œä½†ç°åœ¨è¯å®äº†è¿™ä¸€ç‚¹ã€‚<!-- raw HTML omitted -->ğŸ”»è”é»éƒ¨é˜Ÿæœ¬èº«çš„ç»„æˆä¹Ÿæ˜¯é”™ç»¼å¤æ‚ã€‚æ¬§ç›Ÿæœ‰16ä¸ªå‘è”åˆå›½é©»é»å·´å«©ä¸´æ—¶éƒ¨é˜Ÿï¼ˆè”é»éƒ¨é˜Ÿï¼‰æ´¾é£äººå‘˜çš„å›½å®¶ï¼Œå¾·å›½æ´¾é£äº†200äººï¼Œè´å°”åšå…‹ç­‰äººä¸€ç›´ä»¥è”é»éƒ¨é˜Ÿå‚ä¸å›½çš„èº«ä»½æŒ‡è´£çœŸä¸»å…šã€‚<!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B8%80%E7%81%AB%E7%AE%AD%E5%BC%B9%E6%8E%89%E5%85%A5%E6%88%91%E8%B5%B4%E9%BB%8E%E7%BB%B4%E5%92%8C%E9%83%A8%E9%98%9F%E8%90%A5%E5%8C%BA%23&amp;amp;extparam=%23%E4%B8%80%E7%81%AB%E7%AE%AD%E5%BC%25B">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B8%80%E7%81%AB%E7%AE%AD%E5%BC%B9%E6%8E%89%E5%85%A5%E6%88%91%E8%B5%B4%E9%BB%8E%E7%BB%B4%E5%92%8C%E9%83%A8%E9%98%9F%E8%90%A5%E5%8C%BA%23&amp;amp;extparam=%23%E4%B8%80%E7%81%AB%E7%AE%AD%E5%BC%B</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OC2zWrpU2">ğŸ”»ã€Šçº½çº¦é‚®æŠ¥ã€‹è˜è¯·çš„ä¸€åè¯»å”‡ä¸“å®¶è¯´ï¼Œæ‹œç™»å‘Šè¯‰å¥¥å·´é©¬â€œå¥¹æ²¡æœ‰æˆ‘å¼ºå¤§â€ï¼Œå¥¥å·´é©¬ä¹ŸåŒæ„â€œè¿™æ˜¯äº‹å®ï¼Œå“¥ä½ è¯´çš„å¯¹â€ã€‚ğŸ”»6 åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´çš„å¾®åšè§†é¢‘</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-17</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-oc2zwrpu2/">
    
    
    
    
    
      
    
    ğŸ”»ã€Šçº½çº¦é‚®æŠ¥ã€‹è˜è¯·çš„ä¸€åè¯»å”‡ä¸“å®¶è¯´ï¼Œæ‹œç™»å‘Šè¯‰å¥¥å·´é©¬â€œå¥¹æ²¡æœ‰æˆ‘å¼ºå¤§â€ï¼Œå¥¥å·´é©¬ä¹ŸåŒæ„â€œè¿™æ˜¯äº‹å®ï¼Œå“¥ä½ è¯´çš„å¯¹â€ã€‚<!-- raw HTML omitted -->ğŸ”»6 <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->åŒ…å®¹ä¸‡ç‰©æ’æ²³æ°´çš„å¾®åšè§†é¢‘<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;source &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/OBVMunsA7">è¶Šä¾†è¶Šå¯æ„› - è½¬å‘ @é¡¶ç­†TENä½¿:&amp;ensp;ä¹…ä¿å²ç»ªé‡Œ via.NOGI46ann&amp;nogizaka46 X [å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-17</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-obvmunsa7/">
    
    
    
    
    
      
    
    è¶Šä¾†è¶Šå¯æ„›<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@é¡¶ç­†TENä½¿<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted --> via.NOGI46ann&amp;nogizaka46 X &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax2.sinaimg.cn/large/006z6nxLgy1huooiy0lb9j31kw">https://tvax2.sinaimg.cn/large/006z6nxLgy1huooiy0lb9j31kw</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/OBXNAqRil">åŒæ™‚é–“å¿™underliveå’Œèˆå°åŠ‡ï¼ŒçœŸè¾›è‹¦ï¼ - è½¬å‘ @AyaTea:&amp;ensp;å‰ç”°ç»«ä¹ƒ#å‰ç”°ç»«ä¹ƒã‚¯ãƒªã‚¹ãƒ†ã‚£ãƒ¼##å‰ç”°ç»«ä¹ƒå…‹è‰ä¸è’‚# ï¼¼ï¼¼èˆå°å‰§æ°´æœç¯®å­è·ç¦»å¼€å¹•è¿˜å‰©1ï¸âƒ£å¤©ï¼ï¼ï¿½...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-17</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-obxnaqril/">
    
    
    
    
    
      
    
    åŒæ™‚é–“å¿™underliveå’Œèˆå°åŠ‡ï¼ŒçœŸè¾›è‹¦ï¼<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@AyaTea<!-- raw HTML omitted -->:â€‚<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->å‰ç”°ç»«ä¹ƒ<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D1">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D1</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OBYEKphHa">ä¹…ä¿å²ç»ªé‡Œ â—¤â—¢â—¤ï¿£ï¿£ï¿£#ä¸‰å±±å‡Œè¾‰##ä¹…ä¿å²ç»ªé‡Œ# ä¸»æ¼”ğŸ¬ã€#èª°ã‚ˆã‚Šã‚‚ã¤ã‚ˆãæŠ±ãã—ã‚ã¦ï¼ˆç´§ç´§æ‹¥æŠ±ï¼‰#ã€ å†³å®šäº ğŸšæœˆğŸŸæ—¥(å‘¨äº”)ä¸Šæ˜ ï¼ ä¸»è§†è§‰å›¾ä¹Ÿè§£ç¦å•¦ğŸ«§ ...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-17</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-obyekphha/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted -->â—¤â—¢â—¤ï¿£ï¿£ï¿£<!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B8%89%E5%B1%B1%E5%87%8C%E8%BE%89%23&amp;amp;extparam=%23%E4%B8%89%E5%B1%B1%E5%87%8C%E8%BE%89%23">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B8%89%E5%B1%B1%E5%87%8C%E8%BE%89%23&amp;amp;extparam=%23%E4%B8%89%E5%B1%B1%E5%87%8C%E8%BE%89%23</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OBYMczhS9">ä¹…ä¿å²ç»ªé‡Œ#shiorigram# Kyun [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-17</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-obymczhs9/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#shiorigram#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted -->Kyun &lt;img style=&quot;&quot;  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OBYN13XjZ">ä¹…ä¿å²ç»ªé‡Œ#ä¹…ä¿å²ç»ªé‡Œæ‰‹æœºåš# 2024.10.17 18:06ã€Œæ¬¸å˜¿ã€æ€è€ƒå„ç§äº‹æƒ…æ—¶æ—¶é—´å“‡ï½ï½åœ°å°±è¿‡å»äº†ï¼Œï¼Œç§¯ç´¯äº†è®¸å¤šè¿™ä¹Ÿè¦åšé‚£ä¹Ÿè¦åšçš„äº‹æƒ…å‘¢ã€‚æœ€è¿‘ï¼Œç»å¸¸ä¼šåšå¥‡æ€ªçš„æ¢¦...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-17</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-obyn13xjz/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%9C%BA%E5">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%9C%BA%E5</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OC0b8AbLO">ä¹…ä¿å²ç»ªé‡Œ ã€Œè¢«æœªæ¥çš„æˆ‘æš´å‡»ï¼ã€EP.7 é¡¶ç­†TENä½¿çš„å¾®åšè§†é¢‘</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-17</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-oc0b8ablo/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted -->ã€Œè¢«æœªæ¥çš„æˆ‘æš´å‡»ï¼ã€EP.7 <!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; src=&ldquo;<a href="https://h5.sinaimg.cn/upload/2015/09">https://h5.sinaimg.cn/upload/2015/09</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OC0Bq84ZX">ä¹…ä¿å²ç»ªé‡Œ ã€ŒTVLIFEã€ No.21ç¿»è¯‘ç¨ç­‰ [å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-17</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-oc0bq84zx/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted --> ã€ŒTVLIFEã€ No.21<!-- raw HTML omitted --><!-- raw HTML omitted -->ç¿»è¯‘ç¨ç­‰ <!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax2.sinaimg.cn/large/006z6nxLgy">https://tvax2.sinaimg.cn/large/006z6nxLgy</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OC0tv1FFi">ä¹…ä¿å²ç»ªé‡Œ#shiorigram# 2025å¹´2æœˆ7æ—¥ä¸Šæ˜ ç”µå½±ã€æ¯”ä»»ä½•äººéƒ½è¦ç´§ç´§æ‹¥æŠ±ã€æ—¢æ¸©æš–åˆå†·æ¼ ã€‚ç»†è…»å´åˆå¤§èƒ†ï¼Œå¿ƒçµçš„æ¸©åº¦ã€å£°éŸ³ã€é¢œè‰²ã€‚ è¿™æ˜¯ä¸€éƒ¨é¢å¯¹äº†æ‰€æœ‰ä¸å¯å¿½è§†çš„äº‹...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-17</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-oc0tv1ffi/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#shiorigram#&lt; &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6117592326/OBWIbbFfy">I dreamed a dreamç«Ÿç„¶æ•´ä¸ªä¸‰é‡å”±[doge] æ¸¡è¾¹è’¼ç‚çš„å¾®åšè§†é¢‘</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-17</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6117592326-obwibbffy/">
    
    
    
    
    
      
    
    I dreamed a dreamç«Ÿç„¶æ•´ä¸ªä¸‰é‡å”±<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->æ¸¡è¾¹è’¼ç‚çš„å¾®åšè§†é¢‘<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;video &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6117592326/OBWwzyyFW">ä¼˜é›…[doge] [å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-17</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6117592326-obwwzyyfw/">
    
    
    
    
    
      
    
    ä¼˜é›…<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.npr.org/2024/10/17/1210938289/how-we-vote-throwback">How We Vote (Throwback)</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-17</span>
  </div>
  <div class="summary">
    <a href="/post/www-npr-org-2024-10-17-1210938289-how-we-vote-throwback/">
    
    
    
    
    
      
    
    Drunken brawls, coercion, and lace curtains: believe it or not, how regular people vote was not something the Founding Fathers thought much about. Americans went from casting votes at wild parties in the town square to doing so in private booths, behind a drawn curtain. In this episode, the process of voting: how it was designed, who it was meant for, and the moments when we reimagined it altogether.<!-- raw HTML omitted --><!-- raw HTML omitted -->Learn more about sponsor message choices: <!-- raw HTML omitted -->podcastchoices.com/adchoices<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://www.npr.org/about-npr/179878450/privacy">https://www.npr.org/about-npr/179878450/privacy</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39408682/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1x5bM_TNL8gjogAcnslpo2s2PbDe-61JVM2h9yowOYSiZ7Dkrt&amp;fc=20220919211934&amp;ff=20241016183238&amp;v=2.18.0.post9&#43;e462414">SSCI: Self-Supervised Deep Learning Improves Network Structure for Cancer Driver Gene Identification</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-16</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39408682-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1x5bm-tnl8gjogacnslpo2s2pbde-61jvm2h9yowoysiz7dkrt-fc-20220919211934-ff-20241016183238-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The pathogenesis of cancer is complex, involving abnormalities in some genes in organisms. Accurately identifying cancer genes is crucial for the early detection of cancer and personalized treatment, among other applications. Recent studies have used graph deep learning methods to identify cancer driver genes based on biological networks. However, incompleteness and the noise of the networks will weaken the performance of models. To address this, we propose a cancer driver gene &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39408682/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1x5bM_TNL8gjogAcnslpo2s2PbDe-61JVM2h9yowOYSiZ7Dkrt&amp;fc=20220919211934&amp;ff=20241017182614&amp;v=2.18.0.post9&#43;e462414">SSCI: Self-Supervised Deep Learning Improves Network Structure for Cancer Driver Gene Identification</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-16</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39408682-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1x5bm-tnl8gjogacnslpo2s2pbde-61jvm2h9yowoysiz7dkrt-fc-20220919211934-ff-20241017182614-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The pathogenesis of cancer is complex, involving abnormalities in some genes in organisms. Accurately identifying cancer genes is crucial for the early detection of cancer and personalized treatment, among other applications. Recent studies have used graph deep learning methods to identify cancer driver genes based on biological networks. However, incompleteness and the noise of the networks will weaken the performance of models. To address this, we propose a cancer driver gene &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39409160/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241016183241&amp;v=2.18.0.post9&#43;e462414">Targeting Bone Tumours with 45S5 Bioactive Glass</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-16</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39409160-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241016183241-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Despite advances in treatment modalities, bone tumour therapies still face significant challenges. Severe side effects of conventional approaches, such as chemo- and radiation therapy, result in poor survival rates and high tumour recurrence rates, which are the most common issues that need to be improved upon. The aim of this study was to evaluate the therapeutic properties of 45S5 bioactive glass (BG) for targeting bone tumours. The viability of the cells derived from &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39409405/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241016183241&amp;v=2.18.0.post9&#43;e462414">Brain Function, Learning, and Role of Feedback in Complete Paralysis</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-16</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39409405-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241016183241-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The determinants and driving forces of communication abilities in the locked-in state are poorly understood so far. Results from an experimental-clinical study on a completely paralyzed person involved in communication sessions after the implantation of a microelectrode array were retrospectively analyzed. The aim was to focus on the prerequisites and determinants for learning to control a brain-computer interface for communication in paralysis. A comparative examination of the &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39409845/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241016183241&amp;v=2.18.0.post9&#43;e462414">Interdisciplinary Animal Research Ethics-Challenges, Opportunities, and Perspectives</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-16</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39409845-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241016183241-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Can nonhuman animals be used for the benefit of humans in a scientifically and morally justified manner and, if yes, how? Based on our own experiences as scholars from various academic backgrounds, we argue that this question can only be answered as an interdisciplinary and international endeavor, considering insights from research ethics and animal ethics as well as scientific and legal aspects. The aim of this article is to contribute to the foundation of the emerging field of animal &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39409885/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241016183241&amp;v=2.18.0.post9&#43;e462414">Germline Polymorphisms Associated with Overall Survival in Lung Adenocarcinoma: Genome-Wide Analysis</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-16</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39409885-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241016183241-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: This study highlights a potential regulatory role of the identified polymorphisms in influencing outcome and suggests a mechanistic link between these variants, gene expression regulation, and lung adenocarcinoma prognosis. Validation and functional studies are warranted to elucidate the mechanisms underlying these &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39409886/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241016183241&amp;v=2.18.0.post9&#43;e462414">Unravelling the Complexity of HNSCC Using Single-Cell Transcriptomics</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-16</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39409886-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241016183241-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: This review highlights the contributions of scRNAseq to HNSCC research, addressing its cellular and biological complexity, and emphasizes its potential for advancing research and clinical practice in other cancer &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39410037/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241016183241&amp;v=2.18.0.post9&#43;e462414">Impact of T Cell Ratios on Survival in Pleural Mesothelioma: Insights from Tumor Microenvironment Analysis</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-16</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39410037-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241016183241-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Background: Immunotherapy has significantly improved overall survival in patients with pleural mesothelioma, yet this benefit does not extend to those with the epithelioid subtype. Tumor growth is believed to be influenced by the immune response. This study aimed to analyze the tumor microenvironment to gain a better understanding of its influence on tumor growth. Methods: The tumor immune cell infiltration of 188 patients with pleural mesothelioma was characterized by &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39410588/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241016183241&amp;v=2.18.0.post9&#43;e462414">Neck Reflex Points: A New Clinical Test? Prevalence in Two Cohorts and Its Covariates</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-16</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39410588-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241016183241-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Background: Neck reflex points (NRPs) are 2 Ã— 6 potentially tender areas of the neck, denominated NRP-C0 to NRP-C7. They are different from muscular trigger points and become tender in response to chronic trigeminal irritation. NRP examination has a high inter-rater reproducibility. We investigated the prevalence of NRPs in two populations to investigate their usefulness as a clinical test for trigeminal irritation. Methods: In total, 165 patients with chronic pain and 431 students were &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39410624/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241016183241&amp;v=2.18.0.post9&#43;e462414">Predicting the Malignancy Grade of Soft Tissue Sarcomas on MRI Using Conventional Image Reading and Radiomics</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-16</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39410624-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241016183241-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Objectives: This study aims to investigate MRI features predicting the grade of STS malignancy using conventional image reading and radiomics. Methods: Pretherapeutic imaging data regarding size, tissue heterogeneity, peritumoral changes, necrosis, hemorrhage, and cystic degeneration were evaluated in conventional image reading. Furthermore, the tumors' apparent diffusion coefficient (ADC) values and radiomics features were extracted and analyzed. A random forest machine learning algorithm &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39410643/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241016183241&amp;v=2.18.0.post9&#43;e462414">Factors Influencing Background Parenchymal Enhancement in Contrast-Enhanced Mammography Images</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-16</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39410643-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241016183241-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Background: The aim of this study is to evaluate the correlation between background parenchymal enhancement (BPE) and various patient-related and technical factors in recombined contrast-enhanced spectral mammography (CESM) images. Material and Methods: We assessed CESM images from 62 female patients who underwent CESM between May 2017 and October 2019, focusing on factors influencing BPE. A total of 235 images, all acquired using the same mammography machine, were analyzed. A region of &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39410806/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241016183241&amp;v=2.18.0.post9&#43;e462414">DNA methylation-array interlaboratory comparison trial demonstrates highly reproducible paediatric CNS tumour classification across 13 international centres</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-16</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39410806-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241016183241-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Our study demonstrates remarkable concordance in DNA methylation profiling and profile interpretation across 12 international centres. These findings underscore the potential contribution of DNA methylation analysis to the harmonisation of brain tumour &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39410908/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241016183241&amp;v=2.18.0.post9&#43;e462414">Epistemological Misunderstandings of the German Federal Court of Justice in Criminal Cases Regarding the Null Hypothesis: Verification in the Credibility Assessment</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-16</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39410908-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241016183241-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Epistemological Misunderstandings of the German Federal Court of Justice in Criminal Cases Regarding the Null Hypothesis: Verification in the Credibility Assessment Abstract: Background: The article deals with the decision of the German Federal Court of Justice (Bundesgerichtshof, BGH) in criminal matters regarding credibility assessment dated 30 July 1999 (1 StR 618/98, BGHSt 45, 164). Regarding criminal matters, the BGH formulated specific requirements for credibility assessments based on &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39410979/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241016183241&amp;v=2.18.0.post9&#43;e462414">A research data management (RDM) community for ELIXIR</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-16</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39410979-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241016183241-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Research data management (RDM) is central to the implementation of the FAIR (Findable Accessible, Interoperable, Reusable) and Open Science principles. Recognising the importance of RDM, ELIXIR Platforms and Nodes have invested in RDM and launched various projects and initiatives to ensure good data management practices for scientific excellence. These projects have resulted in a rich set of tools and resources highly valuable for FAIR data management. However, these resources remain &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39411374/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1x5bM_TNL8gjogAcnslpo2s2PbDe-61JVM2h9yowOYSiZ7Dkrt&amp;fc=20220919211934&amp;ff=20241016183238&amp;v=2.18.0.post9&#43;e462414">Transparent sparse graph pathway network for analyzing the internal relationship of lung cancer</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-16</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39411374-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1x5bm-tnl8gjogacnslpo2s2pbde-61jvm2h9yowoysiz7dkrt-fc-20220919211934-ff-20241016183238-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    While it is important to find the key biomarkers and improve the accuracy of disease models, it is equally important to understand their interaction relationships. In this study, a transparent sparse graph pathway network (TSGPN) is proposed based on the structure of graph neural networks. This network simulates the action of genes in vivo, adds to prior knowledge, and improves the model&rsquo;s accuracy. First, the graph connection was constructed according to protein-protein interaction networks &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39411374/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1x5bM_TNL8gjogAcnslpo2s2PbDe-61JVM2h9yowOYSiZ7Dkrt&amp;fc=20220919211934&amp;ff=20241017182614&amp;v=2.18.0.post9&#43;e462414">Transparent sparse graph pathway network for analyzing the internal relationship of lung cancer</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-16</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39411374-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1x5bm-tnl8gjogacnslpo2s2pbde-61jvm2h9yowoysiz7dkrt-fc-20220919211934-ff-20241017182614-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    While it is important to find the key biomarkers and improve the accuracy of disease models, it is equally important to understand their interaction relationships. In this study, a transparent sparse graph pathway network (TSGPN) is proposed based on the structure of graph neural networks. This network simulates the action of genes in vivo, adds to prior knowledge, and improves the model&rsquo;s accuracy. First, the graph connection was constructed according to protein-protein interaction networks &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39411450/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241016183241&amp;v=2.18.0.post9&#43;e462414">DECOMICS, a shiny application for unsupervised cell type deconvolution and biological interpretation of bulk omic data</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-16</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39411450-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241016183241-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    SUMMARY: Unsupervised deconvolution algorithms are often used to estimate cell composition from bulk tissue samples. However, applying cell-type deconvolution and interpreting the results remain a challenge, even more without prior training in bioinformatics. Here, we propose a tool for estimating and identifying cell type composition from bulk transcriptomes or methylomes. DECOMICS is a shiny-web application dedicated to unsupervised deconvolution approaches of bulk omic data. It provides (i) &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39412366/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241016183241&amp;v=2.18.0.post9&#43;e462414">SARS-CoV-2 ORF 3a-mediated currents are inhibited by antiarrhythmic drugs</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-16</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39412366-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241016183241-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Class III antiarrhythmic drugs are potential inhibitors of ORF 3a-mediated currents, offering new options for the treatment of COVID-19-related cardiac &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39412405/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241016183241&amp;v=2.18.0.post9&#43;e462414">Addressing the Generalizability of AI in Radiology Using a Novel Data Augmentation Framework with Synthetic Patient Image Data: Proof-of-Concept and External Validation Classification Tasks in Multiple Sclerosis</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-16</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39412405-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241016183241-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    &ldquo;Just Accepted&rdquo; papers have undergone full peer review and have been accepted for publication in Radiology: Artificial Intelligence. This article will undergo copyediting, layout, and proof review before it is published in its final version. Please note that during production of the final copyedited article, errors may be discovered which could affect the content. Artificial intelligence (AI) models often face performance drops after deployment to external datasets. This study evaluated &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39412492/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241016183241&amp;v=2.18.0.post9&#43;e462414">Polygenic risk scores stratify breast cancer risk among women with benign breast disease</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-16</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39412492-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241016183241-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: BC risks are elevated among women with BBD and increase progressively with PRS, suggesting that optimal combinations of these factors may improve risk &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39412548/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241016183241&amp;v=2.18.0.post9&#43;e462414">Correction: Conservative or liberal oxygen targets in patients on venoarterial extracorporeal membrane oxygenation</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-16</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39412548-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241016183241-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39412597/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241016183241&amp;v=2.18.0.post9&#43;e462414">Pembrolizumab in combination with radiochemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck: results of the KEYNOTE-412 study and the challenges of radioimmunotherapy</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-16</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39412597-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241016183241-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39412787/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241016183241&amp;v=2.18.0.post9&#43;e462414">Toward Equitable Interventions in Public Mental Health: A Review</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-16</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39412787-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241016183241-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS AND RELEVANCE: In moving toward more equitable interventions in public mental health, it is imperative to adopt an approach that integrates multiple frameworks to address the complexity of mental health inequities. At the core of this integrated approach is the recognition that mental health exists on a continuum. Intersectionality theory can help to identify the root (fundamental) causes of mental health while participatory and settings-based approaches ensure that interventions &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39412871/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241016183241&amp;v=2.18.0.post9&#43;e462414">Surveillance of travel-associated isolates elucidates the diversity of non-pandemic &lt;em&gt;Vibrio cholerae&lt;/em&gt;</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-16</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39412871-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241016183241-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Vibrio cholerae is a Gram-negative bacterium found in aquatic environments and is the aetiological agent of cholera, characterized by acute watery diarrhoea and severe dehydration. Cholera presents a significant global health burden of an estimated 1.3-5 million annual cases, with the current pandemic caused by a toxigenic lineage of the O1 El Tor biotype called seventh pandemic El Tor (7PET) that is still ongoing. Whilst it is known that non-7PET lineages can cause sporadic disease, little &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39413379/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241016183200&amp;v=2.18.0.post9&#43;e462414">Acne Fulminans</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-16</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39413379-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241016183200-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39413379/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241017182613&amp;v=2.18.0.post9&#43;e462414">Acne Fulminans</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-16</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39413379-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241017182613-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39413380/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241016183200&amp;v=2.18.0.post9&#43;e462414">Case 32-2024: A 72-Year-Old Woman with Dyspnea, Dysphagia, and Dysarthria</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-16</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39413380-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241016183200-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39413380/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241017182613&amp;v=2.18.0.post9&#43;e462414">Case 32-2024: A 72-Year-Old Woman with Dyspnea, Dysphagia, and Dysarthria</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-16</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39413380-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241017182613-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39413381/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241016183200&amp;v=2.18.0.post9&#43;e462414">Therapy for Hodgkin&#39;s Lymphoma - Can It Get Any Better?</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-16</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39413381-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241016183200-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39413381/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241017182613&amp;v=2.18.0.post9&#43;e462414">Therapy for Hodgkin&#39;s Lymphoma - Can It Get Any Better?</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-16</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39413381-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241017182613-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39413382/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241016183200&amp;v=2.18.0.post9&#43;e462414">HIV-Positive Organ Donation as Standard of Care in Transplantation</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-16</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39413382-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241016183200-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39413382/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241017182613&amp;v=2.18.0.post9&#43;e462414">HIV-Positive Organ Donation as Standard of Care in Transplantation</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-16</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39413382-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241017182613-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39413383/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241016183200&amp;v=2.18.0.post9&#43;e462414">RENOIR Trial - RSVpreF Vaccine Efficacy over Two Seasons</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-16</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39413383-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241016183200-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39413383/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241017182613&amp;v=2.18.0.post9&#43;e462414">RENOIR Trial - RSVpreF Vaccine Efficacy over Two Seasons</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-16</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39413383-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241017182613-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39413384/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241016183200&amp;v=2.18.0.post9&#43;e462414">Critical Health Care Challenges for the Next U.S. President</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-16</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39413384-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241016183200-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39413384/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241017182613&amp;v=2.18.0.post9&#43;e462414">Critical Health Care Challenges for the Next U.S. President</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-16</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39413384-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241017182613-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39413385/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241016183200&amp;v=2.18.0.post9&#43;e462414">Two Trials of Therapeutics for MASH with Liver Fibrosis</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-16</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39413385-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241016183200-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39413385/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241017182613&amp;v=2.18.0.post9&#43;e462414">Two Trials of Therapeutics for MASH with Liver Fibrosis</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-16</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39413385-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241017182613-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39413386/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241016183200&amp;v=2.18.0.post9&#43;e462414">Two Trials of Therapeutics for MASH with Liver Fibrosis</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-16</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39413386-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241016183200-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39413386/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241017182613&amp;v=2.18.0.post9&#43;e462414">Two Trials of Therapeutics for MASH with Liver Fibrosis</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-16</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39413386-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241017182613-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39413387/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241016183200&amp;v=2.18.0.post9&#43;e462414">Two Trials of Therapeutics for MASH with Liver Fibrosis</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-16</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39413387-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241016183200-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39413387/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241017182613&amp;v=2.18.0.post9&#43;e462414">Two Trials of Therapeutics for MASH with Liver Fibrosis</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-16</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39413387-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241017182613-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39413388/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241016183200&amp;v=2.18.0.post9&#43;e462414">Two Trials of Therapeutics for MASH with Liver Fibrosis. Reply</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-16</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39413388-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241016183200-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39413388/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241017182613&amp;v=2.18.0.post9&#43;e462414">Two Trials of Therapeutics for MASH with Liver Fibrosis. Reply</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-16</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39413388-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241017182613-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39413389/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241016183200&amp;v=2.18.0.post9&#43;e462414">Two Trials of Therapeutics for MASH with Liver Fibrosis. Reply</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-16</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39413389-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241016183200-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39413389/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241017182613&amp;v=2.18.0.post9&#43;e462414">Two Trials of Therapeutics for MASH with Liver Fibrosis. Reply</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-16</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39413389-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241017182613-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39413390/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241016183200&amp;v=2.18.0.post9&#43;e462414">More on Monoclonal Gammopathy of Thrombotic Significance</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-16</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39413390-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241016183200-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39413390/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241017182613&amp;v=2.18.0.post9&#43;e462414">More on Monoclonal Gammopathy of Thrombotic Significance</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-16</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39413390-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241017182613-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39413391/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241016183200&amp;v=2.18.0.post9&#43;e462414">More on Monoclonal Gammopathy of Thrombotic Significance. Reply</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-16</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39413391-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241016183200-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39413391/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241017182613&amp;v=2.18.0.post9&#43;e462414">More on Monoclonal Gammopathy of Thrombotic Significance. Reply</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-16</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39413391-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241017182613-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39413392/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241016183200&amp;v=2.18.0.post9&#43;e462414">Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-16</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39413392-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241016183200-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39413392/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241017182613&amp;v=2.18.0.post9&#43;e462414">Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-16</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39413392-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241017182613-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39413393/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241016183200&amp;v=2.18.0.post9&#43;e462414">Response to PARP Inhibition in &lt;em&gt;BARD1&lt;/em&gt;-Mutated Refractory Neuroblastoma</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-16</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39413393-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241016183200-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39413393/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20241017182613&amp;v=2.18.0.post9&#43;e462414">Response to PARP Inhibition in &lt;em&gt;BARD1&lt;/em&gt;-Mutated Refractory Neuroblastoma</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-16</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39413393-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20241017182613-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39413830/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1Rkszs2HVZ2RHP33OibaNFew6VK-LzjJWTD4GwmLlk8B-wCceh&amp;fc=20220923065203&amp;ff=20241017182600&amp;v=2.18.0.post9&#43;e462414">The Role of CAR T-Cell Therapy in Relapsed/Refractory Adult B-ALL</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-16</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39413830-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1rkszs2hvz2rhp33oibanfew6vk-lzjjwtd4gwmllk8b-wcceh-fc-20220923065203-ff-20241017182600-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CAR T-cell therapy is a recent therapeutic advancement that has transformed the management of relapsed/refractory (R/R) B-cell acute lymphoblastic leukemia (B-ALL). To date, there are 2 FDA-approved CAR-T products for R/R B-ALL: tisagenlecleucel in patients aged &lt;26 years and brexucabtagene autoleucel in those aged â‰¥18 years. This review summarizes the pivotal clinical trials that led to FDA approval of these 2 products and highlight emerging data addressing key questions pertinent to &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39414608/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1jUKNaekwK5-jhnLOsYRQeEvu-lGfd382Ao3uOl7PziqjjxYZK&amp;fc=20220919201732&amp;ff=20241017182555&amp;v=2.18.0.post9&#43;e462414">Clinical features of 20 cases with Pneumocystis jirovecii pneumonia after allogeneic hematopoietic stem cell transplantation</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-16</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39414608-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1juknaekwk5-jhnlosyrqeevu-lgfd382ao3uol7pziqjjxyzk-fc-20220919201732-ff-20241017182555-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    This study included 20 patients with hematological diseases who developed Pneumocystis jirovecii pneumonia (PJP) after receiving allogeneic hematopoietic stem cell transplantation (allo-HSCT) from April 2014 to October 2022 at Peking University People&rsquo;s Hospital. The 20 patients comprised 13 males (65.0% ) and seven females (35.0% ), with a median age of 34 (19-60) years. Eleven cases (55.0% ) of acute myeloid leukemia, four cases (20.0% ) of acute lymphocytic leukemia, two cases (10.0% ) &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39414769/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1Rkszs2HVZ2RHP33OibaNFew6VK-LzjJWTD4GwmLlk8B-wCceh&amp;fc=20220923065203&amp;ff=20241017182600&amp;v=2.18.0.post9&#43;e462414">Immune effector cell-associated enterocolitis following chimeric antigen receptor T-cell therapy in multiple myeloma</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-16</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39414769-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1rkszs2hvz2rhp33oibanfew6vk-lzjjwtd4gwmllk8b-wcceh-fc-20220923065203-ff-20241017182600-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    We report 14 cases of immune effector cell (IEC)-associated enterocolitis following chimeric antigen receptor T-cell (CAR-T) therapy in multiple myeloma, with a 1.2% incidence overall (0.2% for idecabtagene vicleucel and 2.2% for ciltacabtagene autoleucel). Patients developed acute-onset symptoms (typically non-bloody Grade 3+ diarrhea) with negative infectious workup beginning a median of 92.5 days (range: 22-210 days) after CAR-T therapy and a median of 85 days after cytokine release &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39415016/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241017182615&amp;v=2.18.0.post9&#43;e462414">The cool brown dwarf Gliese 229 B is a close binary</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-16</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39415016-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241017182615-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Owing to their similarities with giant exoplanets, brown dwarf companions of stars provide insights into the fundamental processes of planet formation and evolution. From their orbits, several brown dwarf companions are found to be more massive than theoretical predictions given their luminosities and the ages of their host stars^(1-3). Either the theory is incomplete or these objects are not single entities. For example, they could be two brown dwarfs each with a lower mass and &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39415065/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241017182615&amp;v=2.18.0.post9&#43;e462414">Ultra-high-energy gamma-ray bubble around microquasar V4641 Sgr</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-16</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39415065-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241017182615-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Microquasars are laboratories for the study of jets of relativistic particles produced by accretion onto a spinning black hole. Microquasars are near enough to allow detailed imaging of spatial features across the multiwavelength spectrum. The recent extension measurement of the spatial morphology of a microquasar, SS 433, to TeV gamma raysÂ¹ localizes the acceleration of electrons at shocks in the jet far from the black holeÂ². V4641 Sagittarii (V4641 Sgr) is a similar binary system with a &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39415125/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241017182615&amp;v=2.18.0.post9&#43;e462414">Right-to-left-shunts in patients scheduled for neurosurgical intervention in semi-sitting position - a literature review based on two case scenarios</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-16</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39415125-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241017182615-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Perioperative transesophageal echocardiography is a diagnostic tool to both detect intraoperative position-related air embolisms and to rule out intracardiac right-to-left shunts, e.g. a patent foramen ovale, in order to decide for or against a (semi-)sitting position. Depending on the surgical circumstances a semi-sitting positioning of patients presenting with an intracardiac right-to-left-shunt, e.g. a PFO, can be feasible in individual cases if there is an &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39415149/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241017182615&amp;v=2.18.0.post9&#43;e462414">The impact of physical activity on progression-free and overall survival in metastatic breast cancer based on molecular subtype</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-16</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39415149-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241017182615-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Self-reported physical activity using the IPAQ questionnaire did not significantly affect PFS or OS in patients suffering from metastatic breast cancer. Nevertheless, some hypothesis-generating differences between molecular subtypes could be observed, which may be interesting to evaluate &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39415153/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241017182615&amp;v=2.18.0.post9&#43;e462414">VISIT STROKE: non-inferiority of telemedicine-based neurological consultation for post-acute stroke patients - protocol of a prospective observational controlled multi-center study</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-16</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39415153-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241017182615-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    BACKGROUND: Telemedicine provides specialized medical expertise in underserved areas where neurological expertise is frequently not available on a daily basis for hospitalized stroke patients. While tele-consultations are well established in acute stroke assessment, the value of telemedicine-based ward-rounds in the subsequent in-patient stroke management is &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/39415250/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20241017182615&amp;v=2.18.0.post9&#43;e462414">A comprehensive lifestyle index and its associations with DNA methylation and type 2 diabetes among Ghanaian adults: the rodam study</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-16</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-39415250-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20241017182615-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: In this explorative epigenome-wide association study among Ghanaians, we identified one DMP and DMR associated with a comprehensive lifestyle index not previously associated with individual lifestyle factors. Based on our findings, we infer that lifestyle factors in combination, affect DNA methylation, thereby influencing the risk of T2DM among Ghanaian adults living in different &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/OBMAdjC32">æœ‰ä¸€å€‹å°å°å°ä¹…ä¿é†¬ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-16</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-obmadjc32/">
    
    
    
    
    
      
    
    æœ‰ä¸€å€‹å°å°å°ä¹…ä¿é†¬ <!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/OBMFfBnG6">è½‰ç™¼å¾®åš - è½¬å‘ @æœå’©ç³–ç³–æ¨:&amp;ensp;TVLIFE 24å¹´11æœˆ1æ—¥å·ä¹…ä¿å²ç»ªé‡Œ ä¼Šè—¤ä¸‡ç†å&amp;é…’äº•éº»è¡£ [å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-16</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-obmffbng6/">
    
    
    
    
    
      
    
    è½‰ç™¼å¾®åš<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å‘ <!-- raw HTML omitted -->@æœå’©ç³–ç³–æ¨<!-- raw HTML omitted -->:â€‚TVLIFE 24å¹´11æœˆ1æ—¥å·<!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ ä¼Šè—¤ä¸‡ç†å&amp;é…’äº•éº»è¡£ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax1.sinaimg.cn/large/db7db933gy1hunxe9hgl7j225y32ax6t.jpg%22">https://tvax1.sinaimg.cn/large/db7db933gy1hunxe9hgl7j225y32ax6t.jpg&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/OBOUcFANO">åˆºå®¢ä¿¡æ¢ä¹…ä¿ç·’ [å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-16</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-oboucfano/">
    
    
    
    
    
      
    
    åˆºå®¢ä¿¡æ¢ä¹…ä¿ç·’ <!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/5402554084/OBPG9vLa1">ä½ ç·’å–œæ­¡æµ·çºå› [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-16</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-5402554084-obpg9vla1/">
    
    
    
    
    
      
    
    ä½ ç·’å–œæ­¡æµ·çºå› <!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OBLVrwknF">ä¹…ä¿å²ç»ªé‡Œ#ä¹…ä¿å²ç»ªé‡Œæ‰‹æœºåš# 2024.10.15 11:36ã€Œå‘œå“‡å•Šã€æ—©ä¸Šå¥½ã€œä»Šå¤©ä¹Ÿä»ä»Šæ—©å¼€å§‹å°±åœ¨å·¥ä½œï½æ˜¯æ—©èµ·éå¸¸æˆåŠŸçš„æ—©ä¸Šå¥½ï¼ï¼ä»Šå¤©ä¹Ÿè¦åŠªåŠ›å–½ä»Šå¤©ä¹Ÿæƒ³è¿‡æˆç¾å¥½çš„ä¸€...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-16</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-oblvrwknf/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%9C%BA%E5%25">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%9C%BA%E5%</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OBOHrkZqh">ä¹…ä¿å²ç»ªé‡Œ#ä¹…ä¿å²ç»ªé‡Œæ‰‹æœºåš# 2024.10.16 15:28ã€Œå“‡å•Šã€å‘œå“‡ãƒ¼ãƒ¼ãƒ¼æ„Ÿè§‰å¿˜äº†ä»€ä¹ˆçš„æ—¶å€™ï¼Œå¤§æ¦‚å°±æ˜¯å¿˜äº†ä»€ä¹ˆå§è¯¶å˜¿å˜¿</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-16</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-obohrkzqh/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%9C%BA%E5%8D%9A%23&amp;amp;isnewpage=1%22">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%9C%BA%E5%8D%9A%23&amp;amp;isnewpage=1&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OBOIAjoMT">ä¹…ä¿å²ç»ªé‡Œ#shiorigram# ä»Šå¤©ä¹ŸåŠ æ²¹å§Â· Â· ï¸¶ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-16</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-oboiajomt/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#shiorigram#<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted -->ä»Šå¤©ä¹ŸåŠ æ²¹å§Â· Â·<!-- raw HTML omitted -->  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OBOLRxSfb">ä¹…ä¿å²ç»ªé‡Œ[è€¶][å¯çˆ±][è€¶] - è½¬å‘ @ä¹ƒæœ¨å‚46:&amp;ensp;ğŸ“¸#ä¹ƒæœ¨å‚46GALLERY#ğŸ“¸[é€èŠ±èŠ±]#3æœŸç”Ÿ# Works[é€èŠ±èŠ±]ä¹ƒæœ¨å‚46 #ä¹…ä¿å²ç»ªé‡Œ# #ä½è—¤æ«# #å‘äº•å¶æœˆ# #å‰ç”°...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-16</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-obolrxsfb/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OBP1lvz6t">ä¹…ä¿å²ç»ªé‡Œ#ä¹…ä¿å²ç»ªé‡Œæ‰‹æœºåš# 2024.10.16 17:28ã€Œè¯¶å˜¿å˜¿ã€&lt;å›¾&gt;å˜¿å˜¿å˜¿å—¯ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-16</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-obp1lvz6t/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;span &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OBP31oEMn">ä¹…ä¿å²ç»ªé‡Œ ç¬¬91å±Šnhkå…¨å›½å­¦æ ¡åˆå”±å¤§èµ›åˆä¸­ç»„ ä¹…ä¿å²ç»ªé‡Œcut é¡¶ç­†TENä½¿çš„å¾®åšè§†é¢‘</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-16</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-obp31oemn/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted -->ç¬¬91å±Šnhkå…¨å›½å­¦æ ¡åˆå”±å¤§èµ›åˆä¸­ç»„ ä¹…ä¿å²ç»ªé‡Œcut <!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; src=&ldquo;<a href="https://h5.sinaimg.c">https://h5.sinaimg.c</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OBPnojzgC">ä¹…ä¿å²ç»ªé‡Œ#ä¹…ä¿å²ç»ªé‡Œæ‰‹æœºåš# 2024.10.16 18:03ã€Œæœ‰å“¦ã€&lt;å›¾&gt;ä¹Ÿæœ‰è¿™æ ·çš„ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-16</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-obpnojzgc/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;span &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OBQ968QVQ">ä¹…ä¿å²ç»ªé‡Œ#shiorigram# æˆ‘çš„æ¨ä»¬æ¥è¿æ¥æˆ‘äº†ã€‚æœ€å–œæ¬¢äº†ã€‚ğŸ¦¦ğŸ¦¦ğŸ«¶ [å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-16</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-obq968qvq/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#shiorigram#<!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OBRSpeyqv">ä¹…ä¿å²ç»ªé‡Œ via.NOGI46ann&amp;nogizaka46 X [å›¾ç‰‡][å›¾ç‰‡]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-10-16</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-obrspeyqv/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹…ä¿å²ç»ªé‡Œ<!-- raw HTML omitted --><!-- raw HTML omitted --> via.NOGI46ann&amp;nogizaka46 X <!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax4.sinaimg.cn/large/006z6nxLgy">https://tvax4.sinaimg.cn/large/006z6nxLgy</a> &hellip;
    </a>
  </div>
</section>

</main>
</div>

<script async src="//yihui.name/js/center-img.js"></script>

<footer>

<div class="footer">
  <ul class="menu">
    
    <li><a href="/"><span data-hover="Home">Home</span></a></li>
    
    <li><a href="/about/"><span data-hover="About">About</span></a></li>
    
    <li><a href="/archives/"><span data-hover="Archive">Archive</span></a></li>
    
    <li><a href="/contributor/"><span data-hover="Contributor">Contributor</span></a></li>
    
    <li><a href="/index.xml"><span data-hover="Subscribe">Subscribe</span></a></li>
    
  </ul>
  
  <div class="copyright">Â© <a href="https://rainoffallingstar.github.io">Fallingstar</a> 2023 | <a href="https://github.com/rainoffallingstar">Github</a></div>
  
</div>
</footer>







</body>
</html>

